Edgewise Therapeutics (EWTX) News Today $13.73 +0.34 (+2.54%) Closing price 08/13/2025 04:00 PM EasternExtended Trading$13.73 0.00 (0.00%) As of 05:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EWTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 13 at 12:39 PM | globenewswire.comResearch Analysts Offer Predictions for EWTX FY2029 EarningsAugust 12 at 4:55 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 11 at 10:00 AM | prnewswire.comEdgewise Therapeutics (NASDAQ:EWTX) Given New $49.00 Price Target at Royal Bank Of CanadaAugust 10, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 9, 2025 | globenewswire.comWe're Not Very Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn RateAugust 8, 2025 | finance.yahoo.comEdgewise Therapeutics Advances in Muscular Dystrophy TrialsAugust 8, 2025 | tipranks.comEdgewise Therapeutics shares surge as Q2 loss narrows, beats estimatesAugust 7, 2025 | za.investing.comEdgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business HighlightsAugust 7, 2025 | prnewswire.comEdgewise Therapeutics (EWTX) Projected to Post Earnings on ThursdayAugust 7, 2025 | americanbankingnews.comEdgewise Therapeutics (EWTX) to Release Earnings on ThursdayAugust 7, 2025 | marketbeat.comEdgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing RulesAugust 6, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXAugust 6, 2025 | prnewswire.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.9% - Here's WhyAugust 5, 2025 | marketbeat.comTD Asset Management Inc Invests $730,000 in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)August 5, 2025 | marketbeat.comRaymond James Initiates Strong Buy on Edgewise Therapeutics (EWTX) with $46 PT, Cites EDG-7500 Potential for HCMAugust 1, 2025 | insidermonkey.comEdgewise Therapeutics (NASDAQ:EWTX) Trading Up 8.3% - Time to Buy?July 31, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 31, 2025 | prnewswire.comEdgewise Therapeutics (NASDAQ:EWTX) Now Covered by Analysts at Raymond James FinancialJuly 31, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Takes $827,000 Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)July 30, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Rating of "Moderate Buy" by BrokeragesJuly 30, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 27, 2025 | prnewswire.comReadystate Asset Management LP Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)July 22, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 22, 2025 | prnewswire.comJennison Associates LLC Purchases New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)July 22, 2025 | marketbeat.comEdgewise Therapeutics Inc (EWTX) - Investing.comJuly 20, 2025 | investing.comEWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. ...July 19, 2025 | gurufocus.comEWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law FirmJuly 19, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 18, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 17, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 14, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 12, 2025 | prnewswire.comEdgewise Therapeutics (NASDAQ:EWTX) Trading Up 7.9% - Still a Buy?July 9, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 7, 2025 | prnewswire.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 5, 2025 | marketbeat.comEdgewise Therapeutics Reports Positive Results for Muscular Dystrophy TreatmentJuly 4, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX - MorningstarJuly 3, 2025 | morningstar.comMEdgewise Therapeutics, Inc. (EWTX) Cash Flow - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 3, 2025 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Edgewise Therapeutics (EWTX) and Arcturus Therapeutics (ARCT)July 2, 2025 | theglobeandmail.com13 Best Up and Coming Stocks to Invest In NowJuly 2, 2025 | insidermonkey.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTXJuly 2, 2025 | prnewswire.comWhat is HC Wainwright's Forecast for EWTX Q2 Earnings?July 2, 2025 | marketbeat.comEdgewise Therapeutics stock initiated with Buy rating at H.C. WainwrightJuly 1, 2025 | investing.comHC Wainwright & Co. Initiates Coverage of Edgewise Therapeutics (EWTX) with Buy RecommendationJune 30, 2025 | msn.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up - Should You Buy?June 30, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Earns Buy Rating from Analysts at HC WainwrightJune 30, 2025 | marketbeat.comEdgewise Therapeutics stock holds at $16 target amid trial concernsJune 27, 2025 | investing.comEdgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies - Yahoo FinanceJune 27, 2025 | finance.yahoo.com Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address EWTX Media Mentions By Week EWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼0.220.71▲Average Medical News Sentiment EWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼156▲EWTX Articles Average Week Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Rhythm Pharmaceuticals News Today Nuvalent News Today TG Therapeutics News Today Axsome Therapeutics News Today Lantheus News Today CRISPR Therapeutics News Today ADMA Biologics News Today Abivax News Today Merus News Today Krystal Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access